Douglas K. Bratton - 31 Dec 2024 SCHEDULE 13G/A Report for Aquestive Therapeutics, Inc. Common Stock, Par Value $0.001 Per Share (AQST)

Filing Manager
Douglas K. Bratton
Reporting Manager
BRATTON DOUGLAS K
Security
Aquestive Therapeutics, Inc. Common Stock, Par Value $0.001 Per Share
Symbol
AQST
Shares outstanding
90,787,694 shares
Disclosed Ownership
10,077,434 shares
Ownership
11%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2025, 11:38:04 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BRATTON DOUGLAS K 11% 10,077,434 10,023,384 0 Douglas K. Bratton Individual
MonoLine RX II, L.P. 3.8% 3,468,747 3,468,747 0 John Cochran Vice President of General Partner of General Partner
MonoLine RX III, L.P. 2.9% 2,657,943 2,657,943 0 John Cochran Vice President of General Partner of General Partner
MonoLine RX, L.P. 1.9% 1,688,639 1,688,639 0 John Cochran Vice President of General Partner of General Partner
MonoLine Partners, L.P. 2.1% 1,948,578 1,948,578 0 John Cochran Vice President of General Partner of General Partner
MonoSol Rx Genpar, L.P. 0.1% 47,051 47,051 0 John Cochran Vice President of General Partner